Loading...
Loading...
ORGS| Name | Value |
|---|---|
| Revenues | 6,975.0K |
| Cost of Revenue | 3,231.0K |
| Gross Profit | 3,744.0K |
| Operating Expense | 7,073.0K |
| Operating I/L | -3,329.0K |
| Other Income/Expense | -27,773.0K |
| Interest Income | 559.0K |
| Pretax | -3,570.0K |
| Income Tax Expense | 91.0K |
| Net Income/Loss | -4,127.0K |
Orgenesis Inc. is a biotech company specializing in cell and gene therapies with a focus on developing a Point of Care (POCare) platform. The company's POCare platform includes a pipeline of licensed therapeutics processed and produced in closed automated POCare technology systems across a collaborative network. Orgenesis concentrates on autologous therapies, utilizing closed and automated processing systems validated for compliant production near the patient's point of care. This approach allows for the treatment of the patient at their point of care, generating revenue through the development and licensing of POCare therapeutics and the provision of POCare technology systems.
